Trisodium citrate 46.7% selectively and safely reduces staphylococcal catheter-related bacteraemia

Nephrology Dialysis Transplantation

Volumn 23, Issue 11, 2008, Pages 3592-3598

  Winnett, Georgia ^a   Nolan, Jonathan ^a   Miller, Michael ^a   Ashman, Neil ^a,b  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Antibiotic locking solutions; Catheter related bacteraemia; Staphylococcus aureus

Indexed keywords

ALTEPLASE; CITRALOCK; CITRATE TRISODIUM; GENTAMICIN; HEPARIN; TEICOPLANIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ADULT; AGED; ARTICLE; BACTEREMIA; BLOOD CULTURE; CATHETER; CATHETER INFECTION; CATHETER THROMBOSIS; CLINICAL TRIAL; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DIABETES MELLITUS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG SELECTIVITY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PARESTHESIA; PENICILLIN RESISTANCE; PRIORITY JOURNAL; SINGLE DRUG DOSE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TASTE DISORDER; UNSPECIFIED SIDE EFFECT;

AGED; ANTI-INFECTIVE AGENTS; CATHETERS, INDWELLING; CITRATES; CLINICAL AUDIT; FEMALE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 54149109406     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn299     Document Type: Article

References (31)

1. Jaber BL. Bacterial infections in hemodialysis patients: pathogenesis and prevention. Kidney Int 2005; 67: 2508-2519
2. Kessler M, Hoen B, Mayeux D et al. Bacteremia in patients on chronic hemodialysis. Nephron 1993; 64: 95-100
3. Stevenson KB, Hannah EL, Lowder CA et al. Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data: predicting the impact of NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis 2002; 39: 549-555
4. Taylor G, Gravel D, Johnston L et al. Incidence of bloodstream infection in multicenter inception cohorts of hemodialysis patients. Am J Infect Control 2004; 32: 155-160
5. Rayner HC, Besarab A, Brown WW et al. Vascular access results from the dialysis Outcomes and Practice Patterns Study (DOPPS): performance against Kidney Disease Outcomes Quality Initiative (K/DOQI) Clinical Practice Guidelines. Am J Kidney Dis 2004; 44(Suppl 3): 22-26
6. Weijmer MC, Van Den Dorpel MA, Van Der Ven PJ et al. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J Am Soc Nephrol 2005; 16: 2769-2777
7. Beathard GA. Management of bacteremia associated with tunneled-cuffed hemodialysis catheters. J AmSoc Nephrol 1999; 10: 1045-1049
8. Kovalik E, Raymond J, Albers F et al. A clustering of epidural abscesses in chronic hemodialysis patients: risks of salvaging access catheters in cases of infection. J Am Soc Nephrol 1996; 7: 2264-2267
9. Little MA, O'Riodan A, Lucey B et al. A prospective study of complications associated with cuffed, tunnelled haemodialysis catheters. Nephrol Dial Transplant 2001; 16: 2194-2200
10. Saad TF. Bacteraemia associated with tunnelled, cuffed haemodialysis catheters. Am J Kidney Dis 1999; 34: 1114-1124
11. Almirall J, Gonzalez J, Rello J et al. Infections of hemodialysis catheters: incidence and mechanisms. Am J Nephrol 1989; 9: 454-459
12. Nissenson AR, Dylan ML, Griffiths RI et al. Clinical and economic outcomes of Staphylococcus aureus septicemia in ESRD patients receiving hemodialysis. Am J Kidney Dis 2005; 46: 301-308
13. Danese MD, Griffiths RI, Dylan M et al. Mortality differences among organisms causing septicemia in hemodialysis patients. Hemodial Int 2006; 10: 56-62
14. Reed SD, Friedman JY, Engemann JJ et al. Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 2005; 26: 175-183
15. Marr KA, Sexton DJ, Conlon PJ et al. Catheter-related bacteremia and outcome of attempted salvage in patients undergoing hemodialysis. Ann Intern Med 1997; 127: 275-280
16. Allon M. Dialysis catheter-related bacteremia: treatment and prophylaxis. Am J Kidney Dis 2004; 44: 779-791
17. Yu VL, Goetz A, Wagener M et al. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis, efficacy of antibiotic prophylaxis. N Engl J Med 1986; 315: 91-96
18. Johnson DW, MacGinley R, Kay TD et al. A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters. Nephrol Dial Transplant 2002; 17: 1802-1807
19. Kamal GD, Pfaller MA, Rempe LE et al. Reduced intravascular catheter infection by antibiotic bonding. A prospective, randomized, controlled trial. JAMA 1991; 265: 2364-2368
20. Dahlberg PJ, Agger WA, Singer JR et al. Subclavian hemodialysis catheter infections: a prospective, randomized trial of an attachable silver-impregnated cuff for prevention of catheter-related infections. Infect Control Hosp Epidemiol 1995; 16: 506-511
21. Lok CE, Appleton D, Bhola C et al. Trisodium citrate 4% - an alternative to heparin capping of haemodialysis catheters. Nephrol Dial Transplant 2007; 22; 477-483
22. Grudzinski L, Quinan P, Kwok S et al. Sodium citrate 4% locking solution for central venous dialysis catheters and effective, more cost-efficient alternative to heparin. Nephrol Dial Transplant 2007; 22: 471-476
23. Shanks RM, Donegan NP, Graber ML et al. Heparin stimulates Staphylococcus aureus biofilm formation. Infect Immun 2005; 73: 4596-4606
24. Shanks RM, Sargent JL, Martinez RM et al. Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces. Nephrol Dial Transplant 2006; 21: 2247-2255
25. Food and Drug administration. FDA issues warning on tricitrosol dialysis catheter anticoagulant. 2000
26. Weijmer MC, Debets-Ossenkop YJ, Van Der Vondervoort FJ et al. Superior antimicrobial activity of trisodium citrate over heparin for catheter locking. Nephrol Dial Transplant 2002; 17: 2189-2195
27. Agharazii M, Plamondon I, Lebel M et al. Estimation of heparin leak into the systemic circulation after central venous catheter heparin lock. Nephrol Dial Transplant 2005; 20: 1238-1240
28. Doorrenbos CJ, Van Den Elsen-Hutten M, Heuven MJ et al. Estimation of trisodium citrate (Citra-lock) remaining in central venous catheters after the interdialytic interval. Nephrol Dial Transplant 2006; 21: 543-545
29. McIntyre CW, Hulme LJ, Taal M et al. Locking of tunneled hemodialysis catheters with gentamicin and heparin. Kidney Int 2004; 66: 801-805
30. Dogra GK, Herson H, Hutchison B et al. Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J Am Soc Nephrol 2002; 13: 2133-2139
31. Betjes MG, Van Agteren M. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Nephrol Dial Transplant 2004; 19: 1546-1551